CellCompass is the Novartis platform to help you navigate CAR-T therapy for your patients

Information and resources helping you assess your patient’s eligibility for CAR-T therapy, including a mechanism of action video and guide for healthcare professionals.

Call: +800 100-10-100
Not in Europe Click here

Resources

Referral Calculator

Enter key patient characteristics to determine if CAR-T is an option now or in the future.

July 2022

CAR-T cell therapy MOA video

Watch this video to understand the mechanism of action for CAR-T cell therapy.

December 2021

CAR-T cell therapy guide

Learn more about the CAR-T therapy process, referral considerations and considerations for timely access.

November 2021

My T-Cell Therapies site

See how CAR-T immunotherapy is used for treating Acute Lymphoblastic Leukemia (ALL), Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL).

Visit Site

CellCompass is the Novartis platform to help you navigate CAR-T therapy for your patients Information and resources helping you assess your patient’s eligibility for CAR-T therapy, including a mechanism of action video and guide for healthcare professionals.

Resources

My T-Cell Therapies site

CellCompass is the Novartis platform to help you navigate CAR-T therapy for your patients

Information and resources helping you assess your patient’s eligibility for CAR-T therapy, including a mechanism of action video and guide for healthcare professionals.